Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sara Poorfarahani Myers, M.D., Ph.D.

Concepts (127)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sara Myers's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sara Myers has written about over time.
Faculty, Medical, 2 publications between 2018 and 2019, average publication date December 2018. Antifibrinolytic Agents, 2 publications between 2019 and 2020, average publication date August 2019. Tranexamic Acid, 2 publications between 2019 and 2020, average publication date August 2019. Thrombelastography, 1 publications between 2020 and 2020, average publication date February 2020. General Surgery, 4 publications between 2018 and 2022, average publication date February 2020. Venous Thromboembolism, 4 publications between 2019 and 2022, average publication date March 2020. Stereotyping, 1 publications between 2020 and 2020, average publication date June 2020. Internship and Residency, 5 publications between 2018 and 2023, average publication date November 2020. Organizational Culture, 1 publications between 2021 and 2021, average publication date November 2021. Sentinel Lymph Node Biopsy, 1 publications between 2022 and 2022, average publication date April 2022. Neoadjuvant Therapy, 3 publications between 2021 and 2023, average publication date January 2023. Breast Neoplasms, 6 publications between 2022 and 2024, average publication date August 2023. Mammaplasty, 2 publications between 2023 and 2024, average publication date December 2023.

To see the data from this visualization as text, click here.
Myers's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (127)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.